Fatty acid synthase: a new anti-tumor target

被引：6
作者：
Puig, Teresa [1 ,2 ]
Porta, Rut [1 ]
Colomer, Ramon [1 ,3 ]
机构：
[1] Hosp Univ Dr Josep Trueta, Inst Invest Biomed Girona IdIBGi, Inst Catalan Oncol ICO Girona, Girona, Spain
[2] Univ Girona UdG, Fac Med, Girona, Spain
[3] Ctr Oncol MD Anderson Espana, Madrid, Spain
来源：
MEDICINA CLINICA | 2009年 / 132卷 / 09期
关键词：
Cancer; Fatty acid metabolism; Fatty acid synthase; New antitumor drugs; COA-CARBOXYLASE-ALPHA; BREAST-CANCER CELLS; PROSTATE-CANCER; GREEN TEA; THERAPEUTIC TARGET; FAS EXPRESSION; INCREASED RISK; FOOD-INTAKE; INHIBITION; ACTIVATION;
D O I：
10.1016/j.medcli.2008.07.022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Fatty acid synthase (FASN), an enzyme capable of de novo fatty acid synthesis, is highly expressed and activated in most human carcinomas. FASN is associated with poor prognosis in prostate and breast cancer and its inhibition is selectively cytotoxic to human cancer cells. Thus, FASN and fatty acid metabolism have become an important focus for the diagnostic and treatment of cancer. In this sense, there is an increasing interest in identifying and developing new antitumor compounds that inhibit FASN. (C) 2008 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码：359 / 363
页数：5
相关论文
共 50 条
  • [41] Expression and roles of fatty acid synthase in hepatocellular carcinoma
    Hao, Qiwei
    Li, Tao
    Zhang, Xiong
    Gao, Ping
    Qiao, Peiyu
    Li, Sheng
    Geng, Zhimin
    [J]. ONCOLOGY REPORTS, 2014, 32 (06) : 2471 - 2476
  • [42] Synthesis of acyl oleanolic acid-uracil conjugates and their anti-tumor activity
    Mo, Wei-bin
    Su, Chun-hua
    Huang, Jia-yan
    Liu, Jun
    Chen, Zhen-feng
    Cheng, Ke-guang
    [J]. CHEMISTRY CENTRAL JOURNAL, 2016, 10
  • [43] Fatty acid metabolism: A new therapeutic target for cervical cancer
    Ping, Pengbin
    Li, Juan
    Lei, Hongbin
    Xu, Xiaoying
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [44] Fatty acid metabolism: A new target for nasopharyngeal carcinoma therapy
    Li, Juan
    Ping, Pengbin
    Li, Yanhua
    Xu, Xiaoying
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2024, 36 (06)
  • [45] Nanocatalytic Anti-Tumor Immune Regulation
    Li, Mingyuan
    Jiang, Han
    Hu, Ping
    Shi, Jianlin
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2024, 63 (13)
  • [46] Structure, Function and Inhibition of Bcl-2 Family Proteins: A New Target for Anti-Tumor Agents
    Xiao, Guizhi
    Fang, Hao
    Xing, Chengguo
    Xu, Wenfang
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (14) : 1596 - 1604
  • [47] Anti-tumor therapeutic molecules that target the programmed cell death machinery
    Ivanovska, Iva
    Muhoro, Clare N.
    Irusta, Pablo M.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2006, 6 (09) : 1033 - 1042
  • [48] Emerging lactic acid bacteria bacteriocins as anti-cancer and anti-tumor agents for human health
    Niamah, Alaa Kareem
    Al-Sahlany, Shayma Thyab Gddoa
    Verma, Deepak Kumar
    Shukla, Rakesh Mohan
    Patel, Ami R.
    Tripathy, Soubhagya
    Singh, Smita
    Baranwal, Deepika
    Singh, Amit Kumar
    Utama, Gemilang Lara
    Gonzalez, Monica L. Chavez
    Alhilfi, Wissal Audah Hassan
    Srivastav, Prem Prakash
    Aguilar, Cristobal Noe.
    [J]. HELIYON, 2024, 10 (17)
  • [49] High levels of fatty acid synthase expression in esophageal cancers represent a potential target for therapy
    Orita, Hajime
    Coulter, Jonathan
    Tully, Ellen
    Abe, Masaaki
    Montgomery, Elizabeth
    Alvarez, Hector
    Sato, Koichi
    Hino, Okio
    Kajiyama, Yoshiaki
    Tsurumaru, Masahiko
    Gabrielson, Edward
    [J]. CANCER BIOLOGY & THERAPY, 2010, 10 (06) : 549 - 554
  • [50] Increased fatty acid synthase as a therapeutic target in androgen-independent prostate cancer progression
    Pizer, ES
    Pflug, BR
    Bova, GS
    Han, WF
    Udan, MS
    Nelson, JB
    [J]. PROSTATE, 2001, 47 (02) : 102 - 110
12345